Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

UniSA PhD candidate Deepa Nakmode and Professor Sanjay Garg in the lab.A new weekly injectable drug could transform the lives ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...